Aktie A2PNQ9 NEPHROS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Nephros, Inc.

Aktien

A2PNQ9

US6406714005

NEPH

Realtime-Estimate Cboe BZX
Andere Börsenplätze
 17:19:24 02.05.2024 		% 5 Tage % 1. Jan.
2,315 USD -0,22 % Intraday Chart für Nephros, Inc. +5,25 % -33,38 %
07.03. Transcript : Nephros, Inc., Q4 2023 Earnings Call, Mar 07, 2024
07.03. Nephros, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Nephros Schedules First Quarter 2024 Financial Results Conference Call
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Earnings Flash (NEPH) NEPHROS Posts Q3 Revenue $3.7M, vs. Street Est of $3.37M
Nephros Announces Results for Quarter Ended September 30, 2023
Nephros, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nephros, Inc., Hires Judy Krandel as Chief Financial Officer
Nephros Hires Judy Krandel as Chief Financial Officer
Nephros Schedules Third Quarter 2023 Financial Results Conference Call
Nephros to Present at LD Micro Main Event XVI
Earnings Flash (NEPH) NEPHROS Posts Q2 Revenue $3.5M, vs. Street Est of $3.1M
Nephros Announces Results for Quarter Ended June 30, 2023
Nephros, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Nephros Schedules Second Quarter 2023 Financial Results Conference Call
Nephros to Present at LD Micro Invitational XIII
NEPHROS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Nephros Announces Results for Quarter Ended March 31, 2023
Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Nephros Announces CEO Retirement and Succession Plan
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PNQ9 Aktie
  4. Nachrichten Nephros, Inc.
  5. Andere Sprachen